Maxcyte (MXCT) Other Non-Current Liabilities (2020 - 2026)
Maxcyte (MXCT) reported Other Non-Current Liabilities of $262000.0 for Q1 2026, down 2.96% year-over-year from $270000.0 in Q1 2025, and little changed quarter-over-quarter from $263000.0 in Q4 2025.
Maxcyte (MXCT) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has 7 years of Other Non-Current Liabilities data on file, last reported at $262000.0 in Q1 2026.
- Other Non-Current Liabilities for Q1 2026 came in at $262000.0, down 2.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $262000.0 (down 2.96% YoY), and the FY2025 annual result was $263000.0, down 4.01% from the prior year.
- Other Non-Current Liabilities steadied at $262000.0 in Q1 2026 per MXCT's latest filing, from $263000.0 in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $1.3 million in Q4 2022 and troughed at $25000.0 in Q2 2025.
- A 5-year average of $535618.8 and a median of $281000.0 in 2023 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2023 and 2025: Other Non-Current Liabilities jumped 232.93% in 2023, then slumped 91.94% in 2025.
- A 5-year view of Other Non-Current Liabilities shows it stood at $1.3 million in 2022, then sank by 78.56% to $283000.0 in 2023, then declined by 3.18% to $274000.0 in 2024, then slipped by 4.01% to $263000.0 in 2025, then retreated by 0.38% to $262000.0 in 2026.
- Business Quant data shows MXCT's Other Non-Current Liabilities at $262000.0 in Q1 2026, $263000.0 in Q4 2025, and $227000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Maxcyte | 127.72 Mn | 127.72 Mn | 8.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 262,000.00 |
| Dec 31, 2025 | 263,000.00 |
| Sep 30, 2025 | 227,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Mar 31, 2025 | 270,000.00 |
| Dec 31, 2024 | 274,000.00 |
| Sep 30, 2024 | 277,000.00 |
| Jun 30, 2024 | 310,000.00 |
| Mar 31, 2024 | 279,000.00 |
| Dec 31, 2023 | 283,000.00 |
| Sep 30, 2023 | 1.32 Mn |
| Jun 30, 2023 | 1.31 Mn |
| Mar 31, 2023 | 1.31 Mn |
| Dec 31, 2022 | 1.32 Mn |
| Jun 30, 2022 | 393,000.00 |
| Mar 31, 2022 | 451,100.00 |
| Dec 31, 2021 | 450,200.00 |
| Sep 30, 2021 | 496,600.00 |
| Jun 30, 2021 | 1.19 Mn |
| Dec 31, 2020 | 788,800.00 |